Abstract Title:

Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension.

Abstract Source:

Artif Cells Nanomed Biotechnol. 2015 Dec 3:1-8. Epub 2015 Dec 3. PMID: 26631548

Abstract Author(s):

Kevin M Rice, Nandini D P K Manne, Madhukar B Kolli, Paulette S Wehner, Lucy Dornon, Ravikumar Arvapalli, Vellaisamy Selvaraj, Arun Kumar, Eric R Blough

Article Affiliation:

Kevin M Rice

Abstract:

Herein, we investigate whether curcumin nanoparticles (Cur NPs) are effective for the treatment of monocrotaline (MCT)-induced pulmonary arterial hypertension in Sprague Dawley rat. Echocardiography was performed at the start of the study and 28 days after MCT injection. Compared to MCT only animals, Cur NP administration was associated with reduced right ventricular (RV) wall thickness and a decreased right ventricle weight/body weight ratio. Cur NPs also attenuated MCT induced increase in RV mRNA expression of TNF-α and IL-1β. These changes were also associated with decreased RV expression of nitrotyrosine, fibronectin and myosin heavy chain-β.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.